Circio has raised approximately NOK 200M (€18.6M) to advance its [...]

A $2.5m National Institutes of Health award will support research [...]

Agenus has reported deep tumour responses and no observed colorectal [...]

Poolbeg Pharma’s Phase 2a TOPICAL trial is investigating whether POLB [...]

FairJourney Bio has helped engineer a reversible antibody switch designed [...]

A Pusan National University study has identified a signalling pathway [...]

Kupando has dosed the first patient in a Phase 1 [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]